{
  "actions": [
    {
      "acted_at": "2021-07-29",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2021-07-29",
      "action_code": "",
      "committees": [
        "SSFI"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Finance.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s2529-117",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Finance",
      "committee_id": "SSFI"
    }
  ],
  "congress": "117",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2021-07-29",
  "number": "2529",
  "official_title": "A bill to amend the Internal Revenue Code of 1986 to provide for advance refunds of certain net operating losses and research expenditures relating to COVID-19, and for other purposes.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr3623-117",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "IGNITE American Innovation Act",
  "sponsor": {
    "bioguide_id": "M000639",
    "district": null,
    "name": "Menendez, Robert",
    "state": "NJ",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2021-07-29",
  "subjects": [
    "Business expenses",
    "Cardiovascular and respiratory health",
    "Corporate finance and management",
    "Disability assistance",
    "Drug therapy",
    "Emergency medical services and trauma care",
    "Health promotion and preventive care",
    "Health technology, devices, supplies",
    "Income tax credits",
    "Income tax deductions",
    "Infectious and parasitic diseases",
    "Medical research",
    "Medical tests and diagnostic methods",
    "Prescription drugs",
    "Research and development",
    "Taxation"
  ],
  "subjects_top_term": "Taxation",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2021-07-29",
    "date": "2021-11-08T16:46:02Z",
    "text": "Innovation and Growth Now by Investing in Tomorrow's Enterprises Act or the IGNITE American Innovation Act\n\nThis bill allows certain C corporation taxpayers to elect an increased advance refund of net operating loss carryovers attributable to COVID-19 research expenditures in 2020 and 2021. The bill also allows such taxpayers an advance refund of certain other net operating loss carryovers arising during 2015 through 2021.\n\nThe bill allows an increased research tax credit for COVID-19 research expenditures paid or incurred on or after February 15, 2020, and before January 1, 2022."
  },
  "titles": [
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to amend the Internal Revenue Code of 1986 to provide for advance refunds of certain net operating losses and research expenditures relating to COVID-19, and for other purposes.",
      "type": "official"
    },
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "IGNITE American Innovation Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "IGNITE American Innovation Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Innovation and Growth Now by Investing in Tomorrow\u00e2\u20ac\u2122s Enterprises Act",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-01T23:42:30Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/117/s/BILLSTATUS-117s2529.xml"
}